How to treat IBS in pregnancy?
IBS in pregnancy can be difficult to manage as pregnancy digestive issues often intensify or change due to hormonal impact... Read more
Author: InnerBuddies
Updated:
IBS in pregnancy can be difficult to manage as pregnancy digestive issues often intensify or change due to hormonal impact... Read more
ISO-certified EU lab • Sample stays stable during shipping • GDPR-secure data
Digestive symptoms often shift during pregnancy, and for women living with irritable bowel syndrome (IBS) these changes can be puzzling and occasionally unsettling. Understanding the hormonal impact on IBS in pregnancy helps explain why: hormones such as progesterone and estrogen rise steeply and may influence gut motility, visceral sensitivity, and gut-brain signaling. This article explains how pregnancy hormones may affect IBS symptoms, why experiences differ so widely between women, and what role the gut microbiome may play. You will also learn why symptoms alone rarely reveal the full story, and how gut microbiome testing may add personalized context alongside professional prenatal care.
IBS is best understood as a disorder of gut-brain interaction. Its symptoms arise from altered communication between the digestive system and the nervous system, involving motility, sensation, and stress pathways, rather than from visible damage to the gut itself.
Pregnancy transforms this signaling environment. Progesterone, estrogen, relaxin, and human chorionic gonadotropin (hCG) all rise sharply, sometimes reaching concentrations many times higher than before pregnancy. Progesterone is especially relevant because it relaxes smooth muscle throughout the body, including the intestinal wall. That relaxation can slow intestinal transit, which may contribute to constipation, bloating, and excess gas. Estrogen and progesterone may also influence visceral sensitivity, meaning how strongly gut sensations are perceived, and both interact with stress and gut-brain signaling.
An important nuance: research suggests hormones may modulate symptom severity rather than cause IBS outright. Nor is the direction of change predictable. Some women find digestion slows and constipation builds, while others report the opposite.
Digestive health matters more in this period for several reasons. Altered motility and absorption affect everyday comfort, and slower transit may influence how efficiently nutrients from food and supplements become available to mother and baby. The maternal gut and its microbes are also thought to play a role in immune development, with early research suggesting the maternal microbiome may help shape the infant's developing immune system. Gut-brain signaling additionally interacts with the physical and emotional demands of pregnancy, from fatigue to disrupted sleep.
None of this is a cause for alarm. It is simply context for paying closer attention to digestive changes rather than dismissing them as background noise.
The symptoms many readers already recognize include abdominal pain or cramping, bloating, gas, constipation, diarrhea, urgency, and mucus in the stool. The difficulty during pregnancy is that these overlap heavily with normal pregnancy-related digestive changes, which occur even in women without IBS. Patterns are highly individual, and pregnancy-specific IBS research remains limited, so nobody can reliably predict how symptoms will evolve for a particular person.
IBS is commonly grouped into subtypes, including constipation-predominant (IBS-C) and diarrhea-predominant (IBS-D). Hormone-driven slowing of transit may intensify constipation-predominant patterns, because material lingers longer in the colon and more water is absorbed from it. Conversely, some women with diarrhea-predominant IBS report their symptoms easing during pregnancy, possibly because slower transit allows stools to become more formed. Both directions appear in research and anecdotal accounts, and neither is guaranteed. A subtype offers a rough frame for thinking about change, not a prediction.
Every pregnancy differs, but a commonly reported arc looks like this:
Treat this as a general pattern rather than a schedule. Individual experiences can deviate from it substantially.
This is the question most women ask, and the honest answer is that outcomes are mixed. Studies and self-reports describe women who improve, women who worsen, and women who notice no meaningful change at all. Several factors plausibly shape where any individual lands:
The evidence base on IBS specifically during pregnancy is still developing. That uncertainty is normal, and it is no reason for self-blame if your experience does not match anyone else's.
The same symptom can have several contributors. Bloating may reflect hormone-driven slowing of transit, ordinary pregnancy physiology, a change in diet, a new prenatal supplement, or something unrelated to IBS altogether. Constipation may stem from progesterone, iron tablets, reduced movement, or pressure from the growing uterus. Because these causes overlap, symptom patterns alone cannot reliably distinguish between them.
This is why self-diagnosis can mislead in both directions: a new problem may be attributed to pregnancy, or a pregnancy-related change may be mistaken for an IBS flare. It is also why symptom management during pregnancy should be planned with a healthcare provider, since many standard IBS medications are not recommended in pregnancy.
Certain symptoms should never be attributed to IBS or hormones. Contact your midwife, obstetrician, or emergency services promptly if you experience:
These signs call for medical evaluation first. Digestive questions can be explored afterwards, once urgent causes have been ruled out.
Gut microbes and hormones influence each other in a two-way relationship. Research suggests the microbiome shifts across pregnancy, with reported changes in diversity and composition, particularly during the second and third trimesters. Gut bacteria also participate in estrogen metabolism and produce compounds such as short-chain fatty acids (SCFAs), which interact with motility, visceral sensitivity, and immune signaling.
This makes the microbiome one plausible factor in why two women with similar IBS histories can have very different digestive experiences during pregnancy. What it does not establish is causation. Human evidence is still evolving, and observed microbial patterns should not be read as direct explanations for symptoms.
Researchers use the term dysbiosis to describe a microbial pattern considered less favorable. In accessible terms, this can involve reduced microbiome diversity, a decline in beneficial organisms such as short-chain-fatty-acid producers, or increases in organisms associated with gas production or inflammation. Patterns of this kind have been observed in some people with IBS and, separately, in pregnancy.
Two caveats matter. These are associations, not proof that imbalance causes symptoms. And pregnancy-specific microbiome research is still young, so reference points for what a typical pregnant microbiome looks like remain limited.
An at-home gut microbiome test uses a small stool sample to report on microbial composition, diversity, the relative abundance of different organisms, and markers of functional potential, such as the capacity to produce short-chain fatty acids. The sample is collected privately at home and analyzed in a laboratory.
The underlying logic is simple. When hormonal and digestive changes are highly individual, measuring your own microbiome can replace guesswork with a personal reference point. Instead of assuming your gut resembles an average profile, you learn something about your actual microbial balance. That makes testing a source of additional insight, informational rather than a diagnostic shortcut.
A microbiome test may be able to:
It cannot:
Interpretation has limits too. Pregnancy-specific reference ranges are still limited, so results are best read as descriptive information about your individual profile rather than a verdict on your health.
Testing is most relevant when there is a genuine desire to better understand your individual gut profile alongside, not instead of, professional prenatal care. It is a decision about curiosity and context, not urgency.
A microbiome test may be worth considering if one of these scenarios sounds familiar:
Testing is not the right first step in some situations. Red-flag symptoms always require medical evaluation before anything else. Acute illness, or symptoms already being investigated by your obstetric team, also comes first. And if your main goal is a diagnosis, a microbiome test cannot provide one, so a conversation with a clinician is the better starting point.
Hormones are not considered a direct cause of IBS, which is understood as a disorder of gut-brain interaction. However, rising progesterone, estrogen, and hCG may modulate symptom severity by slowing transit and influencing gut sensitivity. New or changing digestive symptoms during pregnancy are always worth discussing with a healthcare provider.
Many standard IBS medications are not recommended during pregnancy, and suitability varies by medication, trimester, and individual circumstances. Any symptom management plan should be agreed with a midwife, obstetrician, or physician rather than arranged on your own.
Some women, particularly those with diarrhea-predominant IBS, report improvement, possibly because hormone-driven slowing of transit allows stools to become more formed. Shifts in diet, stress, and routine may also contribute, and the reasons remain individual and not fully understood.
Progesterone levels peak late in pregnancy, further relaxing intestinal smooth muscle, while the growing uterus adds mechanical pressure on the bowel. Iron supplements, commonly taken in pregnancy, are also associated with constipation, and several of these factors can combine.
Research suggests the microbiome shifts across pregnancy, with reported changes in diversity and composition, especially in the second and third trimesters. These changes appear to be part of normal physiology, though their effects on digestion and immunity are still being studied.
No. A microbiome test describes microbial composition, diversity, and functional potential, but it cannot diagnose IBS or any other condition. IBS diagnosis relies on clinical evaluation by a qualified healthcare professional.
Stool sampling is non-invasive and simply involves collecting a small sample at home, with no physical procedure involved. The main consideration is interpretation, because pregnancy-specific reference ranges are still limited, and testing should complement rather than replace prenatal care.
There is no universally best moment. Some women test early to establish a baseline, while others test later to capture the trimester-related shifts research has described. Whichever you choose, treat the result as a snapshot of that moment in time.
Evidence for probiotics in IBS is mixed, and pregnancy-specific research is limited. Effects also depend on the individual microbiome, which differs from person to person. Consult your healthcare provider before adding any supplement during pregnancy.
Many women report that digestive patterns shift again postpartum as hormone levels fall and the body recovers, but outcomes vary widely, and some symptoms persist or change character. If symptoms remain troublesome, follow up with a healthcare provider.
The hormonal impact on IBS in pregnancy is real, but highly individual. Hormones may slow transit and heighten sensitivity in one woman while coinciding with easier digestion in another. The recurring theme of this article is that symptoms are signals, not explanations: they tell you something is happening, but rarely reveal on their own whether hormones, normal pregnancy physiology, diet, supplements, the microbiome, or something else is responsible.
The science connecting hormones, the microbiome, and IBS is still maturing, and that is worth remembering when weighing any claim about pregnancy digestion. Within those limits, a personalized microbiome analysis can offer a calm, individual starting point for understanding your digestive patterns. Used alongside guidance from your midwife, obstetrician, or physician, this kind of personal context is what personalized gut health is really about: knowing your own gut rather than guessing about it.
hormonal impact on IBS in pregnancy, IBS symptoms during pregnancy, pregnancy hormones and digestion, progesterone and gut motility, gut-brain axis, gut microbiome in pregnancy, microbiome diversity, microbiome imbalance, dysbiosis, short-chain fatty acids, at-home microbiome test, personalized gut health, microbiome testing limitations, postpartum digestive changes
Full microbiome sequencing + Gut Health Index. Metabolic pathways, diversity, keystone species. Personalized plans available (diet, supplements, diary, recipes). EU lab + Maastricht University spin-off + GDPR-safe.
Get the latest gut-health tips and be the first to know about new collections and exclusive offers.